Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C18H22ClNO.ClH |
| Molecular Weight | 340.287 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CN(C)CCOC(C)(C1=CC=CC=C1)C2=CC=C(Cl)C=C2
InChI
InChIKey=PAQUKACYLLABHB-UHFFFAOYSA-N
InChI=1S/C18H22ClNO.ClH/c1-18(21-14-13-20(2)3,15-7-5-4-6-8-15)16-9-11-17(19)12-10-16;/h4-12H,13-14H2,1-3H3;1H
| Molecular Formula | C18H22ClNO |
| Molecular Weight | 303.826 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionCurator's Comment: Description was created based on several sources, including
https://www.drugs.com/international/systral.html
http://en.pharmacodia.com/web/drug/1_10746.html
Curator's Comment: Description was created based on several sources, including
https://www.drugs.com/international/systral.html
http://en.pharmacodia.com/web/drug/1_10746.html
Chlorphenoxamine is an antihistamine and anticholinergic used as an antipruritic and was formerly used in the sympathomimetic treatment of parkinsonism. Histamine receptor H1 antagonist. Chlorphenoxamine is used to treat Allergic conditions, it is reported as an ingredient of Systral in Germany, Malta, Portugal, Thailand, Turkey.
CNS Activity
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| In vitro antibacterial activity of some systemic and topical antihistaminic preparations. | 2009-12-01 |
|
| Spectrophotometric determination of some histamine H1-antagonists drugs in their pharmaceutical preparations. | 2008-01 |
|
| Aspirin-induced unilateral angioedema of the tongue. | 2006-05 |
|
| Simultaneous determination of caffeine, 8-chlorotheophylline, and chlorphenoxamine hydrochloride in ternary mixtures by ratio-spectra zero-crossing first-derivative spectrophotometric and chemometric methods. | 2005-09-13 |
|
| [Significance of chromatographic methods coupled with mass spectrometry for identification of drugs for medico-legal purposes exemplified by chlorphenoxamine]. | 2003-12-13 |
|
| Simultaneous spectrophotometric determination of chlorphenoxamine hydrochloride and caffeine in a pharmaceutical preparation using first derivative of the ratio spectra and chemometric methods. | 2002-05-15 |
|
| [Antimycobacterial antihistaminics]. | 1989-08 |
Patents
Sample Use Guides
Topical/Cutaneous
Allergic conditions
Adult: Apply when required several times daily.
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/20003827
Unknown
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:34:37 GMT 2025
by
admin
on
Mon Mar 31 17:34:37 GMT 2025
|
| Record UNII |
5I159322PY
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29578
Created by
admin on Mon Mar 31 17:34:37 GMT 2025 , Edited by admin on Mon Mar 31 17:34:37 GMT 2025
|
||
|
NCI_THESAURUS |
C29704
Created by
admin on Mon Mar 31 17:34:37 GMT 2025 , Edited by admin on Mon Mar 31 17:34:37 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
11223
Created by
admin on Mon Mar 31 17:34:37 GMT 2025 , Edited by admin on Mon Mar 31 17:34:37 GMT 2025
|
PRIMARY | |||
|
m3457
Created by
admin on Mon Mar 31 17:34:37 GMT 2025 , Edited by admin on Mon Mar 31 17:34:37 GMT 2025
|
PRIMARY | Merck Index | ||
|
SUB01250MIG
Created by
admin on Mon Mar 31 17:34:37 GMT 2025 , Edited by admin on Mon Mar 31 17:34:37 GMT 2025
|
PRIMARY | |||
|
100000084719
Created by
admin on Mon Mar 31 17:34:37 GMT 2025 , Edited by admin on Mon Mar 31 17:34:37 GMT 2025
|
PRIMARY | |||
|
CHEMBL2110774
Created by
admin on Mon Mar 31 17:34:37 GMT 2025 , Edited by admin on Mon Mar 31 17:34:37 GMT 2025
|
PRIMARY | |||
|
DTXSID80971587
Created by
admin on Mon Mar 31 17:34:37 GMT 2025 , Edited by admin on Mon Mar 31 17:34:37 GMT 2025
|
PRIMARY | |||
|
DBSALT002453
Created by
admin on Mon Mar 31 17:34:37 GMT 2025 , Edited by admin on Mon Mar 31 17:34:37 GMT 2025
|
PRIMARY | |||
|
C76671
Created by
admin on Mon Mar 31 17:34:37 GMT 2025 , Edited by admin on Mon Mar 31 17:34:37 GMT 2025
|
PRIMARY | |||
|
C100100
Created by
admin on Mon Mar 31 17:34:37 GMT 2025 , Edited by admin on Mon Mar 31 17:34:37 GMT 2025
|
PRIMARY | |||
|
235422
Created by
admin on Mon Mar 31 17:34:37 GMT 2025 , Edited by admin on Mon Mar 31 17:34:37 GMT 2025
|
PRIMARY | RxNorm | ||
|
209-227-1
Created by
admin on Mon Mar 31 17:34:37 GMT 2025 , Edited by admin on Mon Mar 31 17:34:37 GMT 2025
|
PRIMARY | |||
|
562-09-4
Created by
admin on Mon Mar 31 17:34:37 GMT 2025 , Edited by admin on Mon Mar 31 17:34:37 GMT 2025
|
PRIMARY | |||
|
5I159322PY
Created by
admin on Mon Mar 31 17:34:37 GMT 2025 , Edited by admin on Mon Mar 31 17:34:37 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ENANTIOMER -> RACEMATE | |||
|
|
ENANTIOMER -> RACEMATE | |||
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |